Co-culture of Hepatocytes and Kupffer Cells as an In Vitro Model of Inflammation and Drug-Induced Hepatotoxicity

Sunman, 2004, Kupffer cell-mediated IL-2 suppression of CYP3A activity in human hepatocytes, Drug Metab Dispos, 32, 359, 10.1124/dmd.32.3.359

Corsini, 2012, Current challenges and controversies in drug-induced liver injury, Drug Saf, 35, 1099, 10.1007/BF03261997

Kaplowitz, 2005, Idiosyncratic drug hepatotoxicity, Nat Rev Drug Discov, 4, 489, 10.1038/nrd1750

DeLeve, 1997, Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains, Biochem Pharmacol, 53, 1339, 10.1016/S0006-2952(97)00048-8

Kmiec, 2001, Cooperation of liver cells in health and disease, Adv Anat Embryol Cell Biol, 161, III

Evers, 2013, Critical review of preclinical approaches to investigate cytochrome p450-mediated therapeutic protein drug-drug interactions and recommendations for best practices: a white paper, Drug Metab Dispos, 41, 1598, 10.1124/dmd.113.052225

Liu, 2006, Role of innate immunity in acetaminophen-induced hepatotoxicity, Expert Opin Drug Metab Toxicol, 2, 493, 10.1517/17425255.2.4.493

Dixon, 2013, Kupffer cells in the liver, Compr Physiol, 3, 785, 10.1002/cphy.c120026

Kolios, 2006, Role of Kupffer cells in the pathogenesis of liver disease, World J Gastroenterol, 12, 7413, 10.3748/wjg.v12.i46.7413

Roberts, 2007, Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis, Toxicol Sci, 96, 2, 10.1093/toxsci/kfl173

Hoebe, 2001, Direct cell-to-cell contact between Kupffer cells and hepatocytes augments endotoxin-induced hepatic injury, Am J Physiol Gastrointest Liver Physiol, 280, G720, 10.1152/ajpgi.2001.280.4.G720

Morgan, 2009, Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics, Clin Pharmacol Ther, 85, 434, 10.1038/clpt.2008.302

Wu, 2006, Suppression of hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the central role of proinflammatory cytokines, Int J Mol Med, 18, 339

Higuchi, 2007, Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis, J Surg Res, 137, 46, 10.1016/j.jss.2006.04.019

Harrill, 2009, Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans, Genome Res, 19, 1507, 10.1101/gr.090241.108

Bonzo, 2015, Differential effects of trovafloxacin on TNF-alpha and IL-6 profiles in a rat hepatocyte-Kupffer cell co-culture system, Appl In Vitro Toxicol, 1, 45, 10.1089/aivt.2014.0004

Waxman, 1990, Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response, Biochem J, 271, 113, 10.1042/bj2710113

LeCluyse, 1996, Cultured rat hepatocytes, Pharm Biotechnol, 8, 121, 10.1007/978-1-4899-1863-5_9

Valatas, 2003, Isolation of rat Kupffer cells: a combined methodology for highly purified primary cultures, Cell Biol Int, 27, 67, 10.1016/S1065-6995(02)00249-4

DeLeve, 2006, Rat liver endothelial cells isolated by anti-CD31 immunomagnetic separation lack fenestrae and sieve plates, Am J Physiol Gastrointest Liver Physiol, 291, G1187, 10.1152/ajpgi.00229.2006

Jaeschke, 2007, Kupffer cells, 36

Hanna, 2011, The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes, Nat Immunol, 12, 778, 10.1038/ni.2063

LeCluyse, 1999, Influence of extracellular matrix overlay and medium formulation on the induction of cytochrome P-450 2B enzymes in primary cultures of rat hepatocytes, Drug Metab Dispos, 27, 909

Waring, 2006, Microarray analysis of lipopolysaccharide potentiation of trovafloxacin-induced liver injury in rats suggests a role for proinflammatory chemokines and neutrophils, J Pharmacol Exp Therapeutics, 316, 1080, 10.1124/jpet.105.096347

Shaw, 2007, Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha, Toxicol Sci, 100, 259, 10.1093/toxsci/kfm218

Abdel-Razzak, 1993, Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture, Mol Pharmacol, 44, 707

Poüs, 1990, Effect of recombinant human interleukin-1 beta and tumor necrosis factor alpha on liver cytochrome P-450 and serum alpha-1-acid glycoprotein concentrations in the rat, Drug Metabol Dispos, 18, 467

Ashino, 2004, Involvement of interleukin-6 and tumor necrosis factor a in CYP3A11 and 2C29 down-regulation by Bacillus Calmette-Guérin and lipopolysaccharide in mouse liver, Drug Metabol Dispos, 32, 707, 10.1124/dmd.32.7.707

Rodrigues, 2013, Assessment of an automated in vitro basal cytotoxicity test system based on metabolically-competent cells, Toxicol In Vitro, 27, 760, 10.1016/j.tiv.2012.12.004

LeCluyse, 2012, Organotypic liver culture models: meeting current challenges in toxicity testing, Crit Rev Toxicol, 42, 501, 10.3109/10408444.2012.682115

Jaeschke, 2002, Mechanisms of hepatotoxicity, Toxicol Sci, 65, 166, 10.1093/toxsci/65.2.166

Shaw, 2010, Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity, Toxicol Sci, 118, 7, 10.1093/toxsci/kfq168

Shaw, 2009, Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure, J Pharmacol Exp Ther, 328, 62, 10.1124/jpet.108.143792

Beggs, 2014, Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction, Toxicol Sci, 137, 91, 10.1093/toxsci/kft226

Poulsen, 2014, Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-terminal kinase, J Pharmacol Exp Ther, 349, 185, 10.1124/jpet.113.211276

Harrill, 2009, Population-based discovery of toxicogenomics biomarkers for hepatotoxicity using a laboratory strain diversity panel, Toxicol Sci, 110, 235, 10.1093/toxsci/kfp096

Borlak, 2013, Serum acute phase reactants hallmark healthy individuals at risk for acetaminophen-induced liver injury, Genome Med, 5, 86, 10.1186/gm493

Paul, 2012, Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action, Toxicology, 300, 31, 10.1016/j.tox.2012.05.023

Kale, 2008, Comparative cytotoxicity of alachlor, acetochlor, and metolachlor herbicides in isolated rat and cryopreserved human hepatocytes, J Biochem Mol Toxicol, 22, 41, 10.1002/jbt.20213

Wolf, 2006, Toxicity profiles in rats treated with tumorigenic and nontumorigenic triazole conazole fungicides: propiconazole, triadimefon, and myclobutanil, Toxicol Pathol, 34, 895, 10.1080/01926230601047808

Przybocki, 1992, Involvement of nonparenchymal cells in oxygen-dependent hepatic injury by allyl alcohol, Toxicol Appl Pharmacol, 115, 57, 10.1016/0041-008X(92)90367-2

Rotroff, 2010, Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals, J Toxicol Environ Health B Crit Rev, 13, 329, 10.1080/10937404.2010.483949

Liu, 2015, Predicting hepatotoxicity using ToxCast in vitro bioactivity and chemical structure, Chem Res Toxicol, 28, 738, 10.1021/tx500501h